La Calidad de Vida en el paciente oncológico: estudios del Servicio de Oncología del Hospital de Navarra en el Grupo de Calidad de Vida de la EORTC

ANALES DEL SISTEMA SANITARIO DE NAVARRA

Revisiones

La Calidad de Vida en el paciente oncológico: estudios del Servicio de Oncología del Hospital de Navarra en el Grupo de Calidad de Vida de la EORTC

J.I. Arrarás, T. Dueñas, R. Meiriño, E. Prujá, E. Villafranca, J.J. Valerdi

BIBLIOGRAFÍA

1. Font A. Valoración de la Calidad de Vida en paciente con cáncer (Tesis doctoral). Publicaciones de la Universidad Autónoma de Barcelona. Bellaterra, 1988.

2. Nayfield SG, Ganz PA, Moinpour CM, Cella DF, Hailey BJ. Report from a national cancer institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1992; 1; 203-210.

3. Skeel RT. Quality of Life assessment in cancer clinical trials. It is time to catch up. J Natl Cancer Inst 1989; 81: 472-473.

4. Gough JR. Quality of Life as an outcome variable in oncology and surgery. Aust New Zealand J Surg 1994; 64: 227-235.

5. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 1994; 12: 608-616.

6. Cella D. Measuring Quality of Life in palliative care. Semin Oncol 1995; 22: 73-81.

7. Canales S, Ganz PA, Coscarelli CA. Translation and validation of a quality of life instrument for Hispanic American cancer patients. Qual Life Res 1995; 4: 3-11.

8. Bjordal K, Fren A, Thorvik J, Kaasa S. Patient self-reported and clinician rated Quality of Life in Head and Neck Cancer patients: a cross-sectional study. Eur J Cancer 1995; 31B: 235-241.

9. Presant CA. Quality of Life in cancer patients. Who measures what?. Am J Clin Oncol 1994, 7: 571-573.

10. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient?. Br J Cancer 1988; 57: 109-112.

11. Aaronson NK, Cull A, Kaasa S, Sprangers M. The EORTC modular approach to Quality of Life assessment in Oncology. Int J Ment Health 1994; 23: 75-96.

12. Kiebert G, Kaasa S. Quality of Life in clinical trials: Experience and perspective of the EORTC. J Natl Cancer Inst 1993; 85: 365-376.

13. Aaronson NK, Bullinger M, Ahmezdai S. A modular approach to Quality of Life Assessment in cancer clinical trials. Rec Res Cancer Res 1988; 111: 231-49.

14. Aaronson NK, Ahmezdai S, Bergman B, Bullinger M, Cull A, Duez N et al. The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.

15. Arrarás JI, Illarramendi JJ, Valerdi JJ. El cuestionario de Calidad de Vida de la EORTC, QLQ-C30. Estudio estadístico de validación con una muestra española. Rev Psic Salud 1995; 7: 13-30.

16. Bjordal K, Kaasa S. Psychometric validation of the EORTC core quality of life questionnaire, 30 item version and a diagnosis specific module for head and neck cancer patients. Acta Oncol 1992; 31: 311-321.

17. Bjordal K, Kaasa S, Masterkaasa A. Quality of life in patients treated for head and neck cancer. Int J Radiat Oncol Biol Phys 1994; 28: 847-856.

18. Ringdal GI, Ringdal K. Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993; 2: 129-140.

19. Osoba D, Zee B, Warr D, Kaizer L, Latreille J. Psychometric properties of the EORTC quality of life questionnaire in patients with breast, ovarian and lung cancer. Qual Life Res 1994; 3: 353-364.

20. Fossa SD, Aaronson NK, Newling D, Van Cangh PJ, Denis L, Kurth KH et al. Quality of Life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 1990; 26: 1333-1336.

21. Wolf M, Pritsch M, Drings P, Hans K, Schroeder H, Fletchner H et al. Cyclic-alternating versus response oriented chemotherapy in small-cell lung cancer: a German multicenter randomised trial of 321 patients. J Clin Oncol 1991; 9: 614-624.

22. Hürny C, Bernhard J, Joss R, Willems Y, Cavalli F, Kiser J. Feasibility of quality of life assessment in a randomised phase III trial of small cell lung cancer. Ann Oncol 1992; 3: 825-831.

23. De Boer JB, Van Dam Fsam, Sprangers MAG, Frissen PHJ, Lange JMA. Longitudinal study of the quality of life of symptomatic HIV infected patients in a trial of zidovudine versus zidovudine and interferon alpha. Cancer 1993; 71: 1138-1142.

24. Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK. The EORTC approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993; 2: 287-295.

25. Sprangers MAG, Groenvold M, Arrarás JI, Franklin J, Te Velde A, Muller M et al. The EORTC breast cancer specific quality of life questionnaire module: first results from a three country field study. J Clin Oncol 1996; 14: 2756-2768.

26. Bjordal K, Ahlner-Elmqvist M, Tolleson E, Jensen M, Razavi D, Maher J et al. Development of the EORTC questionnaire module to be used in quality of life assessments in head and neck cancer. Acta Oncol 1994; 33: 879-885.

27. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-C13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994; 30: 635-642.

28. Arrarás JI, Ahmezdai S, Wright S. Progress in the measurement of quality of life in palliative care. En: Jesús Rodríguez Marín (Editor). Health Psychology and quality of life research. Alicante: Promolibro, 1995: 627-636.